Xolair (2019-09-06)
- Starting date:
- September 6, 2019
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-70947
Last updated: 2019-09-09
Summary
-
Product:
Xolair
Reason
Affected lot may contain the presence of silicone oil.
Depth of distribution
Retailers
Affected products
Xolair
DIN, NPN, DIN-HIM
DIN 02260565
Dosage form
Powder For Solution
Strength
Omalizumab 150mg/Vial
Lot or serial number
SR532
Companies
- Recalling Firm
-
Novartis Pharmaceuticals Canada Inc.
2476 Argentia Road, Unit 404
Mississauga
L5N 6M1
Ontario
CANADA
- Marketing Authorization Holder
-
Novartis Pharmaceuticals Canada Inc.
385 Bouchard Boulevard
Dorval
H9S 1A9
Quebec
CANADA